Carvacrol exhibits rapid bactericidal activity against Streptococcus pyogenes through cell membrane damage

Area of Science:

• Microbiology
• Natural Product Chemistry
• Pharmacology

Background:

• Streptococcus pyogenes is a significant global pathogen.
• There is a critical need for new antibiotics due to dwindling development.
• Natural phytochemicals offer a promising alternative for antibacterial therapies.

Purpose of the Study:

• To investigate the antibacterial activity of carvacrol against Streptococcus pyogenes.
• To determine the mechanism of action of carvacrol.
• To evaluate the synergistic effects of carvacrol with conventional antibiotics.

Main Methods:

• In vitro evaluation of carvacrol's Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC).
• Kill curve assays and transmission electron microscopy to assess bactericidal activity and cellular damage.
• Chequerboard assays to determine synergistic effects with clindamycin and penicillin.

Main Results:

• Carvacrol demonstrated potent bactericidal activity against S. pyogenes with MIC and MBC values of 125 µg/mL and 250 µg/mL, respectively.
• Carvacrol compromises bacterial cell membrane integrity, leading to cytoplasmic leakage and cell death.
• Carvacrol exhibited additive to synergistic effects when combined with clindamycin or penicillin.

Conclusions:

• Carvacrol possesses significant in vitro antibacterial activity against Streptococcus pyogenes.
• The mechanism involves disruption of the bacterial cell membrane.
• Carvacrol, alone or in combination with clindamycin/penicillin, represents a potential safe and effective natural therapeutic agent for streptococcal pharyngitis.